Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1420953

Cover Image

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1420953

Assisted Reproductive Technology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

PUBLISHED:
PAGES: 189 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5795
PDF (Multi-user License)
USD 8795
PDF (Corporate License)
USD 11795

Add to Cart

Description

Table of Contents

List of Tables

Assisted Reproductive Technology Market - Scope of Report

TMR's report on the global assisted reproductive technology market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global assisted reproductive technology market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global assisted reproductive technology market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the assisted reproductive technology market.

Market Snapshot
Market Value in 2023US$ 25.9 Bn
Market Value in 2031US$ 58.6 Bn
CAGR9.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global assisted reproductive technology market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global assisted reproductive technology market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global assisted reproductive technology market.

The report delves into the competitive landscape of the global assisted reproductive technology market. Key players operating in the global assisted reproductive technology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global assisted reproductive technology market profiled in this report.

Key Questions Answered in Global assisted reproductive technology Market Report:

  • What is the sales/revenue generated by assisted reproductive technology across all regions during the forecast period?
  • What are the opportunities in the global assisted reproductive technology market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Assisted Reproductive Technology Market - Research Objectives and Research Approach

The comprehensive report on the global assisted reproductive technology market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global assisted reproductive technology market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global assisted reproductive technology market.

Show more
Product Code: TMRGL29234

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Assisted Reproductive Technology Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Technology Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Assisted Reproductive Technology Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Technology/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Assisted Reproductive Technology Market Analysis and Forecast, by Technology

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Technology, 2017-2031
    • 6.3.1. In Vitro Fertilization
      • 6.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 6.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 6.3.2. Artificial Insemination
      • 6.3.2.1. Intrauterine Insemination (IUI)
      • 6.3.2.2. Intracervical Insemination (ICI)
      • 6.3.2.3. Others
    • 6.3.3. Surrogacy
    • 6.3.4. Others
  • 6.4. Market Attractiveness Analysis, by Technology

7. Global Assisted Reproductive Technology Market Analysis and Forecast, by Procedure

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Procedure, 2017-2031
    • 7.3.1. Frozen Donor
    • 7.3.2. Frozen Non-donor
    • 7.3.3. Fresh Donor
    • 7.3.4. Fresh Non-donor
    • 7.3.5. Embryo Banking
  • 7.4. Market Attractiveness Analysis, by Procedure

8. Global Assisted Reproductive Technology Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Fertility Clinics
    • 8.3.2. Hospitals
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Assisted Reproductive Technology Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Assisted Reproductive Technology Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Technology, 2017-2031
    • 10.3.1. In Vitro Fertilization
      • 10.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 10.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 10.3.2. Artificial Insemination
      • 10.3.2.1. Intrauterine Insemination (IUI)
      • 10.3.2.2. Intracervical Insemination (ICI)
      • 10.3.2.3. Others
    • 10.3.3. Surrogacy
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by Procedure, 2017-2031
    • 10.4.1. Frozen Donor
    • 10.4.2. Frozen Non-donor
    • 10.4.3. Fresh Donor
    • 10.4.4. Fresh Non-donor
    • 10.4.5. Embryo Banking
  • 10.5. Market Value Forecast, by End-user, 2017-2031
    • 10.5.1. Fertility Clinics
    • 10.5.2. Hospitals
    • 10.5.3. Others
  • 10.6. Market Value Forecast, by Country, 2017-2031
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Technology
    • 10.7.2. By Procedure
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Assisted Reproductive Technology Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Technology, 2017-2031
    • 11.3.1. In Vitro Fertilization
      • 11.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 11.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 11.3.2. Artificial Insemination
      • 11.3.2.1. Intrauterine Insemination (IUI)
      • 11.3.2.2. Intracervical Insemination (ICI)
      • 11.3.2.3. Others
    • 11.3.3. Surrogacy
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Procedure, 2017-2031
    • 11.4.1. Frozen Donor
    • 11.4.2. Frozen Non-donor
    • 11.4.3. Fresh Donor
    • 11.4.4. Fresh Non-donor
    • 11.4.5. Embryo Banking
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Fertility Clinics
    • 11.5.2. Hospitals
    • 11.5.3. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Technology
    • 11.7.2. By Procedure
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Assisted Reproductive Technology Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Technology, 2017-2031
    • 12.3.1. In Vitro Fertilization
      • 12.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 12.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 12.3.2. Artificial Insemination
      • 12.3.2.1. Intrauterine Insemination (IUI)
      • 12.3.2.2. Intracervical Insemination (ICI)
      • 12.3.2.3. Others
    • 12.3.3. Surrogacy
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Procedure, 2017-2031
    • 12.4.1. Frozen Donor
    • 12.4.2. Frozen Non-donor
    • 12.4.3. Fresh Donor
    • 12.4.4. Fresh Non-donor
    • 12.4.5. Embryo Banking
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Fertility Clinics
    • 12.5.2. Hospitals
    • 12.5.3. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Technology
    • 12.7.2. By Procedure
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Assisted Reproductive Technology Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Technology, 2017-2031
    • 13.3.1. In Vitro Fertilization
      • 13.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 13.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 13.3.2. Artificial Insemination
      • 13.3.2.1. Intrauterine Insemination (IUI)
      • 13.3.2.2. Intracervical Insemination (ICI)
      • 13.3.2.3. Others
    • 13.3.3. Surrogacy
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Procedure, 2017-2031
    • 13.4.1. Frozen Donor
    • 13.4.2. Frozen Non-donor
    • 13.4.3. Fresh Donor
    • 13.4.4. Fresh Non-donor
    • 13.4.5. Embryo Banking
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Fertility Clinics
    • 13.5.2. Hospitals
    • 13.5.3. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Technology
    • 13.7.2. By Procedure
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Assisted Reproductive Technology Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Technology, 2017-2031
    • 14.3.1. In Vitro Fertilization
      • 14.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 14.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 14.3.2. Artificial Insemination
      • 14.3.2.1. Intrauterine Insemination (IUI)
      • 14.3.2.2. Intracervical Insemination (ICI)
      • 14.3.2.3. Others
    • 14.3.3. Surrogacy
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by Procedure, 2017-2031
    • 14.4.1. Frozen Donor
    • 14.4.2. Frozen Non-donor
    • 14.4.3. Fresh Donor
    • 14.4.4. Fresh Non-donor
    • 14.4.5. Embryo Banking
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Fertility Clinics
    • 14.5.2. Hospitals
    • 14.5.3. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Technology
    • 14.7.2. By Procedure
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. Merck KGaA
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Technology Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. CooperSurgical, Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Technology Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. FUJIFILM Irvine Scientific
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Technology Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Vitrolife AB
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Technology Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Hamilton Thorne, Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Technology Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Nikon Corporation
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Technology Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Nidacon International AB
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Technology Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Laboratoire CCD
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Technology Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Esco Micro Pte. Ltd.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Technology Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
Show more
Product Code: TMRGL29234

List of Tables

  • Table 01: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 02: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 03: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 07: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 08: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 11: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 12: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 15: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 16: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 19: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 20: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 23: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 24: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Assisted Reproductive Technology Market Size (US$ Mn) and Distribution (%), by Region, 2017 and 2031
  • Figure 02: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by Technology, 2022
  • Figure 03: Global Assisted Reproductive Technology Market Value Share, by Technology, 2022
  • Figure 04: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by Procedure, 2022
  • Figure 05: Global Assisted Reproductive Technology Market Value Share, by Procedure, 2022
  • Figure 06: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by End-user, 2022
  • Figure 07: Global Assisted Reproductive Technology Market Value Share, by End-user, 2022
  • Figure 08: Global Assisted Reproductive Technology Market Value Share, by Region, 2022
  • Figure 09: Global Assisted Reproductive Technology Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 10: Global Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 11: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 12: Global Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 13: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 14: Global Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 15: Global Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 16: Global Assisted Reproductive Technology Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 17: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 18: North America Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 19: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 20: North America Assisted Reproductive Technology Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 21: North America Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 22: North America Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 23: North America Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 24: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 25: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 26: North America Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 27: Europe Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 28: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 29: Europe Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 30: Europe Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 31: Europe Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 32: Europe Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 33: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 34: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 35: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 36: Asia Pacific Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 37: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 38: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 39: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 40: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 41: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 42: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 43: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 44: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 45: Latin America Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 46: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 47: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 48: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 49: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 50: Latin America Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 51: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 52: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 53: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 54: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 55: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 57: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 58: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 59: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 60: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 61: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 62: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023-2031
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!